US2 conjugated with 111In (γ-emitter) and 90Y (β−-emitter) ([111In]In-US2 and [90Y]Y-US2, respectively) were prepared for tumor single photon emission computed tomography (SPECT) imaging and radionuclide-based therapy targeting CA-IX, respectively. Here, CA9 is linked to neoplasm.